AI assistant
Sending…
PROKIDNEY CORP. — Director's Dealing 2021
Jun 30, 2021
32485_dirs_2021-06-29_41dec4bd-e846-4b68-884a-06333d2c6629.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Social Capital Suvretta Holdings Corp. III (DNAC)
CIK: 0001850270
Period of Report: 2021-06-29
Reporting Person: Semigran Marc (Director)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Class B ordinary shares | $ | Class A ordinary shares (30000) | Direct |
Footnotes
F1: As described in the issuer's registration statement on Form S-1 (File No. 333-256725) under the heading "Description of Securities--Founder Shares," the Class B ordinary shares, par value $0.0001 per share, of the issuer will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustment, and have no expiration date.
More from PROKIDNEY CORP.
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 15
Annual Report
2026
Apr 17
Regulatory Filings
2026
Mar 18
Regulatory Filings
2026
Mar 18
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 2